Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBIT Margin (2020 - 2025)

Stemtech (STEK) has disclosed EBIT Margin for 6 consecutive years, with 39.8% as the latest value for Q3 2025.

  • Quarterly EBIT Margin rose 2965.0% to 39.8% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 48.55% through Sep 2025, down 3360.0% year-over-year, with the annual reading at 47.22% for FY2024, 2404.0% down from the prior year.
  • EBIT Margin hit 39.8% in Q3 2025 for Stemtech, up from 43.13% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 259.19% in Q4 2022 to a low of 323.05% in Q3 2022.
  • Historically, EBIT Margin has averaged 44.5% across 5 years, with a median of 52.22% in 2024.
  • Biggest five-year swings in EBIT Margin: crashed -24201bps in 2022 and later soared 27845bps in 2023.
  • Year by year, EBIT Margin stood at 7.94% in 2021, then skyrocketed by 3363bps to 259.19% in 2022, then crashed by -53bps to 121.67% in 2023, then plummeted by -98bps to 2.52% in 2024, then plummeted by -1677bps to 39.8% in 2025.
  • Business Quant data shows EBIT Margin for STEK at 39.8% in Q3 2025, 43.13% in Q2 2025, and 138.81% in Q1 2025.